1. Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter study
- Author
-
Wenfei Zhang, Xingwang Gu, Bing Li, Shulin Liu, Jingyuan Yang, Yuelin Wang, Shiyu Cheng, Lin Lv, Zhiqing Li, Linna Lu, Jinghong Zhang, Qi Zeng, Zefeng Xiao, Guangfeng Liu, Cai Xin, Tianyu Zhang, Yingdan Su, Minyu Chen, Chengshu Wang, Yonkang Cun, Xinyu Zhao, and Youxin Chen
- Subjects
Polypoidal choroidal vasculopathy ,subfoveal choroidal thickness ,choroidal vascularity index ,anti-VEGF ,nomogram ,Medicine - Abstract
Background Polypoidal choroidal vasculopathy (PCV) is a hemorrhagic fundus disease that can lead to permanent vision loss. Predicting the treatment response to anti-VEGF monotherapy in PCV is consistently challenging. We aimed to conduct a prospective multicenter study to explore and identify the imaging biomarkers for predicting the anti-VEGF treatment response in PCV patients, establish predictive model, and undergo multicenter validation.Methods This prospective multicenter study utilized clinical characteristics and images of treatment naïve PCV patients from 15 ophthalmic centers nationwide to screen biomarkers, develop model, and validate its performance. Patients from Peking Union Medical College Hospital were randomly divided into a training set and an internal validation set. A nomogram was established by univariate, LASSO regression, and multivariate regression analysis. Patients from the other 14 centers served as an external test set. Area under the curve (AUC), sensitivity, specificity, and accuracy were calculated. Decision curve analysis (DCA) and clinical impact curve (CIC) were utilized to evaluate the practical utility in clinical decision-making.Findings The eye distribution for the training set, internal validation set, and external test set were 66, 31, and 71, respectively. The ‘Good responder’ exhibited a thinner subfoveal choroidal thickness (SFCT) (230.67 ± 61.96 vs. 314.42 ± 88.00 μm, p
- Published
- 2024
- Full Text
- View/download PDF